113 related articles for article (PubMed ID: 2704024)
21. DNA binding by antitumor trans-[PtCl2(NH3)(thiazole)]. Protein recognition and nucleotide excision repair of monofunctional adducts.
Kasparkova J; Novakova O; Farrell N; Brabec V
Biochemistry; 2003 Jan; 42(3):792-800. PubMed ID: 12534292
[TBL] [Abstract][Full Text] [Related]
22. Effect of intraperitoneal pristane on established immunity to the adj-PC-5 plasmacytoma.
Potter M; Walters JL
J Natl Cancer Inst; 1973 Sep; 51(3):875-81. PubMed ID: 4743559
[No Abstract] [Full Text] [Related]
23. Selective reduction of cis-diamminedichloroplatinum(II) nephrotoxicity by ebselen.
Baldew GS; McVie JG; van der Valk MA; Los G; de Goeij JJ; Vermeulen NP
Cancer Res; 1990 Nov; 50(21):7031-6. PubMed ID: 2208170
[TBL] [Abstract][Full Text] [Related]
24. Antitumour activity of some platinum compounds.
Chakraborty BK; Biswas N; Choudhury K; Neogy RK; Das Sarma B
Chemotherapy; 1985; 31(1):55-9. PubMed ID: 4038640
[TBL] [Abstract][Full Text] [Related]
25. Structure-activity relationships of the antitumor platinum coordination complexes.
Connors TA; Cleare MJ; Harrap KR
Cancer Treat Rep; 1979; 63(9-10):1499-502. PubMed ID: 498149
[No Abstract] [Full Text] [Related]
26. Synthesis, antitumor activity, and chemical properties of silaplatin and related platinum (II) and platinum (IV) complexes derived from beta-silyl amines.
Anderson WK; Kasliwal R; Houston DM; Wang YS; Narayanan VL; Haugwitz RD; Plowman J
J Med Chem; 1995 Sep; 38(19):3789-97. PubMed ID: 7562909
[TBL] [Abstract][Full Text] [Related]
27. Preparation, characterization, and anticancer activity of a series of cis-PtCl2 complexes linked to anthraquinone intercalators.
Gibson D; Gean KF; Ben-Shoshan R; Ramu A; Ringel I; Katzhendler J
J Med Chem; 1991 Jan; 34(1):414-20. PubMed ID: 1992142
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and antitumor activity of a new cis-diammineplatinum (II) complex containing procaine hydrochloride.
Cafaggi S; Esposito M; Parodi B; Vannozzi MO; Viale M; Pellecchia C; Fulco RA; Merlo F; Zicca A; Cadoni A
Anticancer Res; 1992; 12(6B):2285-92. PubMed ID: 1295476
[TBL] [Abstract][Full Text] [Related]
29. Rationale for the synthesis and preliminary biological evaluation of highly active new antitumor nitrosoureido sugars.
Roger P; Monneret C; Fournier JP; Choay P; Gagnet R; Gosse C; Letourneux Y; Atassi G; Gouyette A
J Med Chem; 1989 Jan; 32(1):16-23. PubMed ID: 2909727
[TBL] [Abstract][Full Text] [Related]
30. Anticancer drugs: estrophilic cisplatin derivatives.
Engel J; Schönenberger H; Lux F; Hilgard P
Cancer Treat Rev; 1987 Dec; 14(3-4):275-83. PubMed ID: 2830970
[TBL] [Abstract][Full Text] [Related]
31. Hydrophobicity parameters for platinum complexes.
Souchard JP; Ha TT; Cros S; Johnson NP
J Med Chem; 1991 Feb; 34(2):863-4. PubMed ID: 1995911
[No Abstract] [Full Text] [Related]
32. In vivo and in vitro effectivity of some platinum complexes.
Balázová E; Hrubisko M; Ujházy V
Neoplasma; 1984; 31(6):641-7. PubMed ID: 6395026
[TBL] [Abstract][Full Text] [Related]
33. Relationships between the aqueous chemistry and the in vitro cytotoxic activities of mixed-amine cisplatin analogues.
Bednarski PJ
Biochem Pharmacol; 1992 Jun; 43(12):2609-20. PubMed ID: 1632817
[TBL] [Abstract][Full Text] [Related]
34. New cisplatin analogues in development. A review.
Weiss RB; Christian MC
Drugs; 1993 Sep; 46(3):360-377. PubMed ID: 7693428
[TBL] [Abstract][Full Text] [Related]
35. Cis-platinum(II) complexes of carboxymethyl-dextran as potential antitumor agents. I. Preparation and characterization.
Schechter B; Pauzner R; Arnon R; Wilchek M
Cancer Biochem Biophys; 1986 Oct; 8(4):277-87. PubMed ID: 2433021
[TBL] [Abstract][Full Text] [Related]
36. Induction of tumor-specific antitumor immunity after chemotherapy with cisplatin in mice bearing MOPC-104E plasmacytoma by modulation of MHC expression on tumor surface.
Nio Y; Hirahara N; Minari Y; Iguchi C; Yamasawa K; Toga T; Tamura K
Anticancer Res; 2000; 20(5A):3293-9. PubMed ID: 11062756
[TBL] [Abstract][Full Text] [Related]
37. Cycloplatam and oxoplatin--the new antitumor platinum compounds of the second generation.
Presnov MA; Konovalova AL
Arch Geschwulstforsch; 1988; 58(1):43-9. PubMed ID: 3285804
[TBL] [Abstract][Full Text] [Related]
38. Transplacental passage of Pt after treatment with the new triamine complex cis-diaminechloro-[2-(diethylamino) ethyl 4-amino-benzoate, N4]-chloride platinum (II) monohydrochloride monohydrate.
Ognio E; Chiavarina B; Caviglioli G; Lapide M; Viale M
Arch Toxicol; 2004 Oct; 78(10):584-8. PubMed ID: 15150682
[TBL] [Abstract][Full Text] [Related]
39. Synthesis, characterization, and biological evaluation of new tetrazole-based platinum(II) and palladium(II) chlorido complexes--potent cisplatin analogues and their trans isomers.
Serebryanskaya TV; Yung T; Bogdanov AA; Shchebet A; Johnsen SA; Lyakhov AS; Ivashkevich LS; Ibrahimava ZA; Garbuzenco TS; Kolesnikova TS; Melnova NI; Gaponik PN; Ivashkevich OA
J Inorg Biochem; 2013 Mar; 120():44-53. PubMed ID: 23305964
[TBL] [Abstract][Full Text] [Related]
40. A new family of water-soluble, third generation antitumor platinum complexes.
Bitha P; Carvajal SG; Citarella RV; Delos Santos EF; Durr FE; Hlavka JJ; Lang SA; Lindsay HL; Thomas JP; Wallace RE
J Med Chem; 1989 Sep; 32(9):2063-7. PubMed ID: 2671371
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
